Bluesky Facebook Reddit Email

Health care providers should be prepared for high prevalence of co-occurring disorders

05.03.04 | NIH/National Institute on Drug Abuse

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Scientists at the University of California–San Francisco conducted a study that addressed these questions. They compared, at treatment entry, 120 substance abuse patients who had co-occurring psychiatric disorders with 106 psychiatric patients who had co-occurring substance abuse disorders. Both patient groups were in public, acute-crisis, residential treatment programs, within either the mental health or substance abuse treatment systems. The researchers speculated that the relative absence of differences between the two patient groups would suggest that the prevalent practice of specialized treatments in separate systems of care for comorbid patients was not clinically indicated.

Dr. Barbara Havassy and her colleagues determined patients' DSM-IV (the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) psychiatric and substance abuse diagnoses and assessed severity of drug abuse and psychiatric symptoms. Few differences between the comorbid groups emerged. There were no diagnostic differences except for those with schizophrenia spectrum disorders. These disorders were slightly more common among psychiatric than substance abuse patients; nevertheless, nearly one-third of substance abuse patients were diagnosed with this disorder. Furthermore, although more substance abuse than psychiatric patients reported recent drug abuse, the average days of drug abuse, among those in each group who reported drug abuse, was not different.

WHAT IT MEANS: Health care providers should recognize the associative nature of drug abuse and mental illness. Substance abuse treatment providers should be prepared to treat patients with severe mental illness. Likewise, mental health treatment providers should be prepared for patients with severe drug problems and long histories of abuse. Other providers and programs, independent of the treatment system, should be aware of the potential for co-occurring disorders and be prepared to offer interventions to their patients.

The researchers published this study in the January 2004 issue of the American Journal of Psychiatry .

American Journal of Psychiatry

Keywords

Article Information

Contact Information

Blair Gately
NIH/National Institute on Drug Abuse
bgately@nida.nih.gov

How to Cite This Article

APA:
NIH/National Institute on Drug Abuse. (2004, May 3). Health care providers should be prepared for high prevalence of co-occurring disorders. Brightsurf News. https://www.brightsurf.com/news/LQMKR3X1/health-care-providers-should-be-prepared-for-high-prevalence-of-co-occurring-disorders.html
MLA:
"Health care providers should be prepared for high prevalence of co-occurring disorders." Brightsurf News, May. 3 2004, https://www.brightsurf.com/news/LQMKR3X1/health-care-providers-should-be-prepared-for-high-prevalence-of-co-occurring-disorders.html.